AU Patent

AU2002253795B2 — Synthesis of 4-Amino-Thalidomide enantiomers

Assigned to Boston Childrens Hospital · Expires 2007-02-01 · 19y expired

What this patent protects

The invention provides new and useful analogs of 4-amino-thalidomide. These analogs include S(−)-4-amino-thalidomide and R(+)-4-amino-thalidomide. The invention also provides processes for making these analogs. Further, the invention provides methods for inhibiting angiogenes…

USPTO Abstract

The invention provides new and useful analogs of 4-amino-thalidomide. These analogs include S(−)-4-amino-thalidomide and R(+)-4-amino-thalidomide. The invention also provides processes for making these analogs. Further, the invention provides methods for inhibiting angiogenesis and treating angiogenesis-associated diseases, including cancer and macular degeneration, by administering these compounds.

Drugs covered by this patent

Patent Metadata

Patent number
AU2002253795B2
Jurisdiction
AU
Classification
—
Expires
2007-02-01
Drug substance claim
No
Drug product claim
No
Assignee
Boston Childrens Hospital
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.